Press release content from Business Wire. The AP news staff was not involved in its creation.
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
February 11, 2021 GMT
OXNARD, Calif. (BUSINESS WIRE) Feb 11, 2021
CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors.
ADVERTISEMENT
After a dedicated run as Chairman of the Board, William Yuan is stepping down and will continue to serve the Company as an advisor and Chairman Emeritus. Rubén José King-Shaw Jr, a highly qualified and respected member of the Board, has been selected to step into that role. Mr. King-Shaw brings with him three decades of executive leadership experience in the healthcare technology and private equity sectors. He recently served on the board of Atlanta-based Cotiviti Holdings, Inc. an